CV
Covista Inc.
CVSA · NYSE
$126.96 +0.44% (+$0.55)
1M -4.25%
Market Cap $4.30B
P/E Ratio 17.11x
Div. Yield -
ROE 17.82%
Bulios Fair Price
$189.84
49.5% upside
Current Price
$126.96
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CVSA is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Strong
8/9Valuation
90 /100
Cheap P/E 17.11x
EV/EBITDA 10.49x
P/FCF 10.96x
Growth
66 /100
Stable EPS growth 23.05%
Rev. growth 11.31%
Book val. growth 3.61%
Profitability
100 /100
Strong Gross margin 57.34%
Net margin 12.87%
FCF margin 20.10%
Quality
74 /100
Excellent ROIC 12.15%
ROE 17.82%
Asset turnover 0.65x
Debt
72 /100
Low Debt/Equity 0.63x
Current ratio 1.09x
Net debt/EBITDA 1.09x
Stability
40 /100
Moderate Beta 0.63x
Rev. volatility 35.12%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CVSA
Online
Sector
Consumer Defensive
Industry
Education & Training Services
CEO
Stephen W. Beard
Employees
4,754
Headquarters
Chicago
Upcoming events
29 OCT
Earnings
Upcoming earnings report